http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015196223-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ecbf525f6c1f592b61917729188ec70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4753cd00109a741aba6c3d71d1ffa166
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2576-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H30-40
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02007
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055
filingDate 2015-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1f2665a350a572c368a461891a0a939
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b3b6b1bc7ecde53c50df53cc0c51936
publicationDate 2015-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2015196223-A1
titleOfInvention System and method for neutral contrast magnetic resonance imaging of calcifications
abstract Systems and methods for magnetic resonance imaging (“MRI”), in which accurate and conspicuous visualization of vascular calcifications and other bony structures can be achieved. An MRI system is operated to perform a pulse sequence that generates substantially similar signal intensity from soft tissues (e.g. muscle, fat, blood) within the body. For instance, blood can be rendered to have a signal intensity that is substantially similar to the vessel wall, while fat and muscle are rendered to appear substantially similar to the vessel wall. With this “neutral” contrast, arterial calcifications, which appear dark due to their low proton density, can be more readily and efficiently visualized by an interpreting physician.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110575168-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10401459-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017097402-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110720047-A
priorityDate 2014-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007038073-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010256480-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007015995-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011245650-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002177770-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012010506-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007078333-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011020456-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 30.